EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization

Pragya Pathak, Krista K Alexander, Leah G Helton, Michalis Kentros, Timothy J LeClair, Xiaojuan Zhang, Franz Y Ho, Timothy T Moore, Scotty Hall, Giambattista Guaitoli, Christian Johannes Gloeckner, Arjan Kortholt und 2 weitere

ACS Chemical Neuroscience · 2023

DOI: 10.1021/acschemneuro.3c00259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Pragya Pathak und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biochemistry, University of Groningen, Nijenborgh 7, 9747AG Groningen, Netherlands. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Peptides. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu, The Michael J. Fox Foundation for Parkinson?s Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesPeptidesLeucine-Rich Repeat Serine-Threonine Protein Kinase-2DimerizationLeucineMutation

Stichwörter der Autor:innen

LRRK2Parkinson’s diseaseallosteric inhibitionconstrained peptideskinasestapled peptide

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LeucineProtein Serine-Threonine KinasesPeptides

Autor:innen und Institutionen

  • Department of Cell Biochemistry, University of Groningen, Nijenborgh 7, 9747AG Groningen, Netherlands.
  • Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.
  • Center for Clinical, Experimental Surgery, and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
  • DZNE German Center for Neurodegenerative Diseases, 72076 Tübingen, Germany.
  • Core Facility for Medical Bioanalytics, Center for Ophthalmology, Institute for Ophthalmic Research, University of Tübingen, 72076 Tübingen, Germany.
  • YETEM-Innovative Technologies Application and Research Centre, Suleyman Demirel University, 32260 Isparta, Turkey.

ORCID-Profile: Eileen J Kennedy

Förderung

  • T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu
  • The Michael J. Fox Foundation for Parkinson?s Research

Zitieren

APA

Pathak, P., Alexander, K. K., Helton, L. G., Kentros, M., LeClair, T. J., Zhang, X., Ho, F. Y., Moore, T. T., Hall, S., Guaitoli, G., Gloeckner, C. J., Kortholt, A., Rideout, H., & Kennedy, E. J. (2023). Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00259

Vancouver

Pathak P, Alexander KK, Helton LG, Kentros M, LeClair TJ, Zhang X, et al. Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00259

BibTeX
@article{Pathak2023,
  author = {Pathak, Pragya and Alexander, Krista K and Helton, Leah G and Kentros, Michalis and LeClair, Timothy J and Zhang, Xiaojuan and Ho, Franz Y and Moore, Timothy T and Hall, Scotty and Guaitoli, Giambattista and Gloeckner, Christian Johannes and Kortholt, Arjan and Rideout, Hardy and Kennedy, Eileen J},
  title = {Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization},
  journal = {ACS Chemical Neuroscience},
  year = {2023},
  doi = {10.1021/acschemneuro.3c00259}
}
Kostenlos starten →